Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare

Clarithromycin is a potent macrolide that has been used for treating infections with nontuberculous mycobacteria. Pairs of susceptible and resistant Mycobacterium intracellulare strains were obtained from patients with chronic pulmonary M. intracellulare infections undergoing monotherapy with clarithromycin. Nucleotide sequence comparisons of the peptidyltransferase region in 23S rRNAs from parental and resistant strains revealed that in three of six resistant strains, for which the MIC was > 32 micrograms/ml, a single base was mutated (Escherichia coli equivalent, A-2058-->G, C, or U). As the modification of adenine 2058 by dimethylation is a frequent cause of macrolide resistance in a variety of different bacteria, we suggest that mutation of A-2058 confers acquired resistance to clarithromycin in M. intracellulare.

[1]  H. Fukuhara,et al.  Erythromycin and spiramycin resistance mutations of yeast mitochondria: nature of the rib2 locus in the large ribosomal RNA gene. , 1984, Nucleic acids research.

[2]  E. A. Morgan,et al.  Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli , 1985, Journal of bacteriology.

[3]  H. Noller.  Structure of ribosomal RNA. , 1984, Annual review of biochemistry.

[4]  E. H. Harris,et al.  Antibiotic resistance mutations in the chloroplast 16S and 23S rRNA genes of Chlamydomonas reinhardtii: correlation of genetic and physical maps of the chloroplast genome. , 1989, Genetics.

[5]  L. Heifets,et al.  Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. , 1992, The American review of respiratory disease.

[6]  H Fukuhara,et al.  Identification of two erythromycin resistance mutations in the mitochondrial gene coding for the large ribosomal RNA in yeast. , 1982, Nucleic acids research.

[7]  R. Wallace,,et al.  Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms , 1992, Antimicrobial Agents and Chemotherapy.

[8]  F. Schmidt,et al.  Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics. , 1983, The Journal of biological chemistry.

[9]  R. Garrett,et al.  A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin. , 1987, Biochimie.

[10]  D. Lane.  16S/23S rRNA sequencing , 1991 .

[11]  R. Wallace,,et al.  Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool , 1993, Journal of clinical microbiology.

[12]  R. Leclercq,et al.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification , 1991, Antimicrobial Agents and Chemotherapy.

[13]  R. Wallace,,et al.  Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system , 1992, Antimicrobial Agents and Chemotherapy.

[14]  M D Collins,et al.  Studies on the ribosomal RNA operons of Listeria monocytogenes. , 1992, FEMS microbiology letters.

[15]  D. Persing,et al.  Elimination of contaminating DNA within polymerase chain reaction reagents: implications for a general approach to detection of uncultured pathogens , 1993, Journal of clinical microbiology.

[16]  H. Noller,et al.  Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. , 1987, Biochimie.

[17]  Ernest Frederick Gale,et al.  The Molecular basis of antibiotic action , 1972 .

[18]  B. Weisblum,et al.  Erythromycin-inducible Resistance in Staphylococcus aureus: Survey of Antibiotic Classes Involved , 1969, Journal of bacteriology.

[19]  N. Lounis,et al.  Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy , 1992, Antimicrobial Agents and Chemotherapy.

[20]  F. Boccard,et al.  Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens. , 1988, The EMBO journal.

[21]  E. Böttger,et al.  Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot , 1993, Molecular microbiology.

[22]  S. Osawa,et al.  Ribosomes from erythromycin-resistant mutants of Escherichia coli Q13. , 1970, Journal of molecular biology.